CY1124640T1 - Μια meθοδος αντιμετωπισης μυκητιασικων μολυνσεων - Google Patents

Μια meθοδος αντιμετωπισης μυκητιασικων μολυνσεων

Info

Publication number
CY1124640T1
CY1124640T1 CY20211100827T CY211100827T CY1124640T1 CY 1124640 T1 CY1124640 T1 CY 1124640T1 CY 20211100827 T CY20211100827 T CY 20211100827T CY 211100827 T CY211100827 T CY 211100827T CY 1124640 T1 CY1124640 T1 CY 1124640T1
Authority
CY
Cyprus
Prior art keywords
treatment
fungal
keratin
humans
animals
Prior art date
Application number
CY20211100827T
Other languages
English (en)
Inventor
Nicole Louise Van Der Weerden
Marilyn Anne Anderson
Original Assignee
Hexima Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55748162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1124640(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hexima Limited filed Critical Hexima Limited
Publication of CY1124640T1 publication Critical patent/CY1124640T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

Η παρούσα γνωστοποίηση σχετίζεται με τον έλεγχο μυκητιασικής μόλυνσης κερατοειδών περιβλημάτων τα οποία καλύπτουν ραχιαίες και τελικές φάλαγγες σε ανθρώπους και ζώα και σχετικών εγκεφαλικών προεξοχών σε ζώα καθώς επίσης υλικού το οποίο περιλαμβάνει κεράτινη σε επιφάνειες ανθρώπων και ζώων. Παράγοντες και φυσικά και συνθετικά σκευάσματα και εκχυλίσματα χρήσιμα για τον έλεγχο μυκητιασικής μόλυνσης των περιβλημάτων αυτών και σχετικών προεξοχών και υλικού το οποίο περιλαμβάνει κεράτινη εμπερικλείονται επίσης από την υποκείμενη γνωστοποίηση. Σε μια υλοποίηση, η παρούσα γνωστοποίηση δίνει οδηγίες για την αντιμετώπιση μυκητιασικής μόλυνσης των νυχιών και ειδικότερα ονυχομυκητίασης σε ανθρώπους.
CY20211100827T 2014-10-21 2021-09-21 Μια meθοδος αντιμετωπισης μυκητιασικων μολυνσεων CY1124640T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462066808P 2014-10-21 2014-10-21
PCT/AU2015/050293 WO2016061619A1 (en) 2014-10-21 2015-05-29 A method of treatment

Publications (1)

Publication Number Publication Date
CY1124640T1 true CY1124640T1 (el) 2022-07-22

Family

ID=55748162

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100827T CY1124640T1 (el) 2014-10-21 2021-09-21 Μια meθοδος αντιμετωπισης μυκητιασικων μολυνσεων

Country Status (23)

Country Link
US (4) US9713632B2 (el)
EP (2) EP3209319B1 (el)
JP (3) JP6646662B2 (el)
KR (1) KR102472312B1 (el)
CN (2) CN113368215A (el)
AU (2) AU2015336933B2 (el)
BR (1) BR112017008211A2 (el)
CA (1) CA2965187A1 (el)
CY (1) CY1124640T1 (el)
DK (1) DK3209319T3 (el)
ES (1) ES2890461T3 (el)
HR (1) HRP20211477T8 (el)
HU (1) HUE056178T2 (el)
LT (1) LT3209319T (el)
MX (2) MX2017005305A (el)
MY (1) MY186552A (el)
NZ (1) NZ731143A (el)
PL (1) PL3209319T3 (el)
PT (1) PT3209319T (el)
RS (1) RS62386B1 (el)
SG (2) SG10201912688YA (el)
SI (1) SI3209319T1 (el)
WO (1) WO2016061619A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
US10568930B2 (en) * 2014-04-24 2020-02-25 Hexima Limited Agents and methods of treatment
US9845342B2 (en) 2014-09-17 2017-12-19 Spogen Biotech Inc. Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
PT3209319T (pt) * 2014-10-21 2021-09-24 Hexima Ltd Um método de tratamento
JP6760970B2 (ja) * 2015-05-29 2020-09-23 ヘキシマ リミテッドＨｅｘｉｍａ Ｌｉｍｉｔｅｄ インビボ治療の方法
US20190275078A1 (en) * 2018-03-09 2019-09-12 Therazure LLC Compositions for the treatment of infections in feet

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3298368A (en) 1964-04-24 1967-01-17 Charos Peter Heated cream applicator gloves
US4087675A (en) 1977-02-07 1978-05-02 Coretta Sansonetti Heated mitten
US4241080A (en) * 1979-05-29 1980-12-23 The Dow Chemical Company Stabilized aqueous antimicrobial composition
US4267852A (en) 1979-09-17 1981-05-19 Hullinger Judith E Process for enhancing and strengthening the growth of nails
JPS5775663A (en) 1980-07-22 1982-05-12 Kiichirou Sarui Apparatus for treating dermatophytosis
US5181914A (en) 1988-08-22 1993-01-26 Zook Gerald P Medicating device for nails and adjacent tissue
US5219877A (en) 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
US5098415A (en) 1990-10-09 1992-03-24 Jack Levin Device and method for using an aqueous solution containing ozone to treat foot diseases
US5156591A (en) 1990-12-13 1992-10-20 S. I. Scientific Innovations Ltd. Skin electrode construction and transdermal drug delivery device utilizing same
JPH0657323A (ja) 1992-08-06 1994-03-01 Sumitomo Metal Ind Ltd 加熱炉におけるバーナー制御方法
JPH0728521A (ja) 1993-07-09 1995-01-31 Yaskawa Electric Corp シミュレーションプログラム自動作成方法
US5449658A (en) 1993-12-07 1995-09-12 Zeneca, Inc. Biocidal compositions comprising polyhexamethylene biguanide and EDTA, and methods for treating commercial and recreational water
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5668084A (en) 1995-08-01 1997-09-16 Zeneca Inc. Polyhexamethylene biguanide and surfactant composition and method for preventing waterline residue
US5795314A (en) 1996-06-19 1998-08-18 Berenstein; Moshe Therapeutic fingernail treatment device
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US5981698A (en) * 1997-06-03 1999-11-09 Cyberchemics, Inc. Antimicrobial polypeptides
US5993790A (en) * 1997-08-04 1999-11-30 Pedinol Pharmacal Inc. Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections
US6165484A (en) * 1997-08-26 2000-12-26 Wake Forest University EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
US6727401B1 (en) 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6235047B1 (en) 1998-04-06 2001-05-22 Augustine Medical, Inc. Wound treatment apparatus with a heater, a heat conductive bandage, and heat-spreading means acting between the heater and bandage
US6572580B2 (en) 1998-08-06 2003-06-03 Profoot, Inc. Set depth nail notcher with patch system and method for treating nail fungus
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US6477410B1 (en) 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6528697B1 (en) 2000-01-03 2003-03-04 Augustine Medical, Inc. Modular bandage
US6281239B1 (en) 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
US7041877B2 (en) * 2001-02-08 2006-05-09 Hexima, Ltd. Defensin-encoding nucleic acid molecules derived from nicotiana alata, uses therfor and transgenic plants comprising same
US6585963B1 (en) 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
EP1393628A4 (en) 2001-06-08 2007-11-14 Ki Chemical Industry Co Ltd MICROORGANISMS KILL THE LIQUID DESODORING AGENT AND PROCESS FOR MICROORGANISM KILLING DESODORATION
EP2270185A3 (en) * 2001-06-22 2012-04-04 Pioneer Hi-Bred International, Inc. Defensin polynucleotides and methods of use
US6821508B2 (en) 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
JP2003123136A (ja) 2001-10-17 2003-04-25 Toshiba Electric Appliance Co Ltd 飲料提供装置
US20030144625A1 (en) 2002-01-28 2003-07-31 Garry Sherman Method and apparatus for the treatment of infections of the nail matrix and nail plate
US6634367B2 (en) 2002-03-25 2003-10-21 Kathleen Hunter Abraham Sealing enclosure for finger tips
US6846837B2 (en) 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
US6921529B2 (en) 2002-07-29 2005-07-26 Joseph C. Maley Treatment modality and method for fungal nail infection
US8486426B2 (en) 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
US20070292355A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20040161452A1 (en) 2003-02-18 2004-08-19 Petit Michael G. Drug-dispensing dressing and composition for treating onychomycosis
EP1648556A1 (en) 2003-07-14 2006-04-26 Power Paper Ltd. Method, apparatus, and kit for onychomycosis treatment using electrokinetic transport of substances
US20050261755A1 (en) 2004-05-24 2005-11-24 Bacino John E Conformable heat transfer pack
US20060013862A1 (en) 2004-07-19 2006-01-19 Held Jerry M Onychomycosis: a new process for cure
JP2006075357A (ja) 2004-09-09 2006-03-23 Institute Of Physical & Chemical Research 水虫の治療装置
NZ560448A (en) 2005-02-16 2009-08-28 Anacor Pharmaceuticals Inc Boron-containing small molecules
JP2008540050A (ja) 2005-05-18 2008-11-20 タイレル、インク 熱を印加して皮膚病変を治療するための治療装置および方法
US7793666B2 (en) 2005-07-28 2010-09-14 Innovation Biomedical Devices, Inc. Apparatus and method for treatment of infected nail
US20070104664A1 (en) 2005-10-26 2007-05-10 California Institute Of Technology Treatment of toenail fungus
CN106008571A (zh) 2005-12-30 2016-10-12 安纳考尔医药公司 含硼的小分子
EP2015757A4 (en) 2006-05-02 2011-01-26 Anacor Pharmaceuticals Inc HYDROLYSERESISTENT, BOROYED THERAPEUTIC USES
WO2008157481A1 (en) 2007-06-15 2008-12-24 Transport Pharmaceuticals, Inc. Method and system for mitigating current concentration in electrokinetic drug delivery
US20090048590A1 (en) 2007-08-15 2009-02-19 Tyrell, Inc. Systems and methods for treating nail-bed fungus through application of heat
ES2324192B1 (es) * 2008-01-30 2010-06-17 PUIG BEAUTY & FASHION GROUP, S.L. Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas.
FR2942716B1 (fr) * 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
IT1395241B1 (it) 2009-08-07 2012-09-05 Iarrera Apparato per la germinazione controllata di semi e relativo metodo.
CN102770123A (zh) 2009-12-23 2012-11-07 纽沃研究股份有限公司 用于治疗甲癣的高渗透性特比萘芬制剂
WO2012027209A2 (en) * 2010-08-23 2012-03-01 Pioneer Hi-Bred International, Inc. Novel defensin variants and methods of use
KR101311196B1 (ko) * 2010-12-23 2013-09-27 중앙대학교 산학협력단 진균 감염 또는 뇌수막염 치료를 위한 ｕｐｒ 신호전달 유전자 ｉｒｅ1 및 ｈｘｌ1의 용도
KR101947126B1 (ko) * 2010-12-28 2019-02-13 카메디스 리미티드 감염의 치료 및 예방을 위한 식물 추출물
EP2664327A1 (en) 2012-05-14 2013-11-20 Almirall S.A. Topical pharmaceutical compositions comprising terbinafide and urea
AR094821A1 (es) * 2012-07-25 2015-09-02 Hanmi Pharm Ind Co Ltd Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada
WO2014078900A1 (en) * 2012-11-23 2014-05-30 Hexima Limited Anti-pathogenic methods
AU2013260696A1 (en) * 2012-11-23 2014-06-12 Hexima Limited Use of anti-fungal defensins
KR20150126042A (ko) * 2013-03-12 2015-11-10 다이닛본 스미토모 세이야꾸 가부시끼가이샤 액체 수성 조성물
CN106231899A (zh) 2014-04-23 2016-12-14 赫希玛有限公司 用于处理病原体的试剂和方法
US10568930B2 (en) 2014-04-24 2020-02-25 Hexima Limited Agents and methods of treatment
PT3209319T (pt) 2014-10-21 2021-09-24 Hexima Ltd Um método de tratamento

Also Published As

Publication number Publication date
CN107106647A (zh) 2017-08-29
US20170239328A1 (en) 2017-08-24
AU2021201810A1 (en) 2021-04-22
MY186552A (en) 2021-07-26
HRP20211477T1 (hr) 2022-01-07
NZ731143A (en) 2021-07-30
HUE056178T2 (hu) 2022-01-28
EP3949977A1 (en) 2022-02-09
CA2965187A1 (en) 2016-04-28
US20210228678A1 (en) 2021-07-29
US10973874B2 (en) 2021-04-13
US20160106807A1 (en) 2016-04-21
ES2890461T3 (es) 2022-01-19
MX2017005305A (es) 2017-08-02
EP3209319A1 (en) 2017-08-30
SG11201703184SA (en) 2017-05-30
JP2020097573A (ja) 2020-06-25
JP2017533210A (ja) 2017-11-09
US20170296622A1 (en) 2017-10-19
EP3209319B1 (en) 2021-07-14
EP3209319A4 (en) 2018-05-16
PT3209319T (pt) 2021-09-24
US10010576B2 (en) 2018-07-03
BR112017008211A2 (pt) 2017-12-26
HRP20211477T8 (hr) 2022-03-04
LT3209319T (lt) 2021-10-25
SI3209319T1 (sl) 2022-01-31
US11446354B2 (en) 2022-09-20
WO2016061619A1 (en) 2016-04-28
JP7207780B2 (ja) 2023-01-18
SG10201912688YA (en) 2020-02-27
JP6990224B2 (ja) 2022-02-03
MX2021006057A (es) 2021-07-06
CN113368215A (zh) 2021-09-10
JP6646662B2 (ja) 2020-02-14
AU2015336933B2 (en) 2021-01-14
JP2022022316A (ja) 2022-02-03
AU2015336933A1 (en) 2017-05-11
CN107106647B (zh) 2021-08-10
KR20170072291A (ko) 2017-06-26
KR102472312B1 (ko) 2022-11-29
DK3209319T3 (da) 2021-10-04
PL3209319T3 (pl) 2021-12-20
US9713632B2 (en) 2017-07-25
RS62386B1 (sr) 2021-10-29

Similar Documents

Publication Publication Date Title
CY1124640T1 (el) Μια meθοδος αντιμετωπισης μυκητιασικων μολυνσεων
CY1123163T1 (el) Αντισωματα που δεσμευουν beta klotho επικρατεια 2 και μεθοδοι χρησης αυτων
EA201792450A1 (ru) Матирующие косметические композиции
EA201790273A1 (ru) Флагеллиновые композиции и их применение
DK3142637T3 (da) Keratin treatment formulations and methods
CY1123963T1 (el) Καινοτομα πολυμερικα προφαρμακα hgh
EA201792006A1 (ru) Антимикробные соединения и способы их получения и их применение
ZA201707494B (en) Hair regrowth treatment and growth stimulant
PH12016502003A1 (en) Novel bacteriophage and composition containing same
CY1123216T1 (el) Αναστολεις της gls1 για την αντιμετωπιση νοσων
CO2017001087A2 (es) Anticuerpos anti proteína similar a angiopoyetina 4
CY1122818T1 (el) Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου
TN2019000106A1 (en) Novel compounds for treating parasitic disease
UY36261A (es) Anticuerpos anti proteína similar a angiopoyetina-4 (angptl4) y métodos de uso
CL2019001649A1 (es) Método para el control de enfermedades bacterianas de plantas utilizando derivados de carboxamida.
MX2017013819A (es) Metodos para la reduccion de grasa.
TWI800561B (zh) 毛髮處理方法
EA202091390A1 (ru) Композиция для потемнения кожи
CY1124597T1 (el) Εκχυλισμα λαδιου gynura procumbens για τη θεραπεια διαφορων δερματολογικων ασθενειων και η διαδικασια παρασκευης του
UA125927U (uk) Засіб для видалення новоутворень шкіри
GT201700017A (es) Un agente de control de enfermedad posterior a cosecha y método de control de enfermedad posterior a cosecha
EA202090146A1 (ru) Косметические композиции и способы применения
UA126148U (uk) Спосіб лікування періімплантного мукозиту
EA201700361A1 (ru) Антицеллюлитный косметический комплекс
UA107725U (uk) Застосування біонанокомпозиту як засобу для лікування уражень поверхневих шарів шкіри у сільськогосподарських тварин